823 related articles for article (PubMed ID: 30242862)
21. 3,6-diazabicyclo[3.3.1]heptanes Induces Apoptosis and Arrests Cell Cycle in Prostate Cancer Cells.
Wei H; Lian W; Wang C
Med Sci Monit; 2020 Jan; 26():e920266. PubMed ID: 31919338
[TBL] [Abstract][Full Text] [Related]
22. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
Wei C; Jing J; Zhang Y; Fang L
Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
[TBL] [Abstract][Full Text] [Related]
23. PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.
Kang M; Lee KH; Lee HS; Park YH; Jeong CW; Ku JH; Kim HH; Kwak C
Prostate; 2016 Feb; 76(3):273-85. PubMed ID: 26499308
[TBL] [Abstract][Full Text] [Related]
24. An EP4 antagonist ONO-AE3-208 suppresses cell invasion, migration, and metastasis of prostate cancer.
Xu S; Zhang Z; Ogawa O; Yoshikawa T; Sakamoto H; Shibasaki N; Goto T; Wang L; Terada N
Cell Biochem Biophys; 2014 Sep; 70(1):521-7. PubMed ID: 24744183
[TBL] [Abstract][Full Text] [Related]
25. Eupatilin Inhibits the Proliferation and Migration of Prostate Cancer Cells through Modulation of PTEN and NF-κB Signaling.
Serttas R; Koroglu C; Erdogan S
Anticancer Agents Med Chem; 2021; 21(3):372-382. PubMed ID: 32781972
[TBL] [Abstract][Full Text] [Related]
26. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer.
Muñoz-Moreno L; Arenas MI; Carmena MJ; Schally AV; Sánchez-Chapado M; Prieto JC; Bajo AM
Oncotarget; 2016 Aug; 7(32):52195-52206. PubMed ID: 27448980
[TBL] [Abstract][Full Text] [Related]
27. Magnolin inhibits prostate cancer cell growth in vitro and in vivo.
Huang Y; Zou X; Zhang X; Wang F; Zhu W; Zhang G; Xiao J; Chen M
Biomed Pharmacother; 2017 Mar; 87():714-720. PubMed ID: 28092770
[TBL] [Abstract][Full Text] [Related]
28. Quercetin Inhibits Cell Migration and Invasion in Human Osteosarcoma Cells.
Lan H; Hong W; Fan P; Qian D; Zhu J; Bai B
Cell Physiol Biochem; 2017; 43(2):553-567. PubMed ID: 28965117
[TBL] [Abstract][Full Text] [Related]
29. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
31. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
32. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer.
Ryo A; Uemura H; Ishiguro H; Saitoh T; Yamaguchi A; Perrem K; Kubota Y; Lu KP; Aoki I
Clin Cancer Res; 2005 Oct; 11(20):7523-31. PubMed ID: 16243827
[TBL] [Abstract][Full Text] [Related]
33. LG308, a Novel Synthetic Compound with Antimicrotubule Activity in Prostate Cancer Cells, Exerts Effective Antitumor Activity.
Qin M; Peng S; Liu N; Hu M; He Y; Li G; Chen H; He Y; Chen A; Wang X; Liu M; Chen Y; Yi Z
J Pharmacol Exp Ther; 2015 Dec; 355(3):473-83. PubMed ID: 26377911
[TBL] [Abstract][Full Text] [Related]
34. Contragestazol (DL111-IT) inhibits proliferation of human androgen-independent prostate cancer cell line PC3 in vitro and in vivo.
He QJ; Yang B; Lou YJ; Fang RY
Asian J Androl; 2005 Dec; 7(4):389-93. PubMed ID: 16281086
[TBL] [Abstract][Full Text] [Related]
35. Fangchinoline induced G1/S arrest by modulating expression of p27, PCNA, and cyclin D in human prostate carcinoma cancer PC3 cells and tumor xenograft.
Wang CD; Huang JG; Gao X; Li Y; Zhou SY; Yan X; Zou A; Chang JL; Wang YS; Yang GX; He GY
Biosci Biotechnol Biochem; 2010; 74(3):488-93. PubMed ID: 20208355
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
38. Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts.
Davis GC; Kong Y; Paige M; Li Z; Merrick EC; Hansen T; Suy S; Wang K; Dakshanamurthy S; Cordova A; McManus OB; Williams BS; Chruszcz M; Minor W; Patel MK; Brown ML
Bioorg Med Chem; 2012 Mar; 20(6):2180-8. PubMed ID: 22364743
[TBL] [Abstract][Full Text] [Related]
39. N'-Formyl-2-(5-nitrothiophen-2-yl)benzothiazole-6-carbohydrazide as a potential anti-tumour agent for prostate cancer in experimental studies.
Rodrigues JR; Charris J; Camacho J; Barazarte A; Gamboa N; Nitzsche B; Höpfner M; Lein M; Jung K; Abramjuk C
J Pharm Pharmacol; 2013 Mar; 65(3):411-22. PubMed ID: 23356850
[TBL] [Abstract][Full Text] [Related]
40. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]